Seasonal flu jab - Clinical trials 

  • Clinical trials

Clinical trials for Flu vaccination

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Flu vaccination. For all clinical trials, go to clinical trials search

This list shows clinical trials for Flu vaccination

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Flu vaccination
Title Recruitment status Location
Immunogenicity of Adjuvanted or Non-adjuvanted H5N1 Booster Vaccine in Adults Primed to A/VN/1194/04 Recruiting United Kingdom
A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine Recruiting United Kingdom
A Study to Assess the Safety and Immunogenicity of a New Influenza Vaccine Candidate MVA-NP+M1 in Healthy Adults Recruiting United Kingdom
Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients Recruiting United Kingdom
A phase III, observer-blind, multicountry, multicentre study to evaluate the safety, reactogenicity and immunogenicity of GlaxoSmithKline Biologicals’ GSK2186877A influenza vaccine administered to adults aged 65 years and older compared to Fluarix™ administered to adults aged 18-41 years and 65 years and older, who previously participated in the 110847 study. - FLU NG-036 EXT:025 Y1 Not Recruiting United Kingdom
A phase II, observer-blind, multicountry, multicentre, randomized study to evaluate the immunogenicity, safety and reactogenicity of the GlaxoSmithKline Biologicals’ influenza vaccine adjuvanted with various doses of the oil in water emulsion and MPL, administered in adults aged 65 years and older, and compared to Fluarix™. - FluAS25-025 PRI Not Recruiting United Kingdom
Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu Not recruiting United Kingdom
Safety and immunogenicity of an intramuscular, inactivated, split-virion, pandemic influenza A/H5N1 vaccine in adults and the elderly. Not Recruiting United Kingdom
Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults Not recruiting United Kingdom
A Phase IV, Single-Centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2010/2011 Formulation of the Enzira® vaccine in Two Groups of Healthy Volunteers: ‘Adults’ (aged 18 to 59 years) and ‘Older Adults’ (aged 60 years or older). Not Recruiting United Kingdom
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member